ChemicalBook > CAS DataBase List > AR 231453

AR 231453

Product Name
AR 231453
CAS No.
733750-99-7
Chemical Name
AR 231453
Synonyms
CS-2809;AR 231453;AR231453; AR-231453;AR 231453, 10 mM in DMSO;AR 231453, GPR119 agonist;N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5;N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-ni;N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amine;inhibit,GPR119,AR-231453,G Protein-Coupled Receptor 119,diabetes,AR231453,AR 231453,insulin,Inhibitor,HIT-T15,glucose,GPCR;(2-FLUORO-4-METHANESULFONYL-PHENYL)-(6-[4-(3-ISOPROPYL-[1,2,4]OXADIAZOL-5-YL)-PIPERIDIN-1-YL]-5-NITRO-PYRIMIDIN-4-YL)-AMINE
CBNumber
CB42597458
Molecular Formula
C21H24FN7O5S
Formula Weight
505.52
MOL File
733750-99-7.mol
More
Less

AR 231453 Property

Melting point:
174-176℃
Boiling point:
703.9±70.0 °C(Predicted)
Density 
1.421±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: 25 mg/ml; DMSO: 3 mg/ml; Ethanol: insol; PBS (pH 7.2): insol
pka
3.24±0.10(Predicted)
form 
Yellow solid.
color 
Light yellow to yellow
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P405Store locked up.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML1883
Product name
AR231453
Purity
≥98% (HPLC)
Packaging
5MG
Price
$92.88
Updated
2025/07/31
Sigma-Aldrich
Product number
SML1883
Product name
AR231453
Purity
≥98% (HPLC)
Packaging
25MG
Price
$436
Updated
2025/07/31
Biosynth Carbosynth
Product number
BA165448
Product name
AR 231453
Packaging
10mg
Price
$130
Updated
2021/12/16
ChemScene
Product number
CS-2475
Product name
AR231453
Purity
99.84%
Packaging
10mg
Price
$130
Updated
2021/12/16
Biosynth Carbosynth
Product number
BA165448
Product name
AR 231453
Packaging
50mg
Price
$465
Updated
2021/12/16
More
Less

AR 231453 Chemical Properties,Usage,Production

Uses

AR 231453 is a potent, specific and orally available GPR119 agonist. AR 231453 can stimulate β-cell replication and improve islet graft function s[1][2].

Biological Activity

AR231453 is a 5-nitropyrimidine derivative th at acts as a highly potent and selective GPR119 agonist (EC50/GPR119 species = 0.4 nM/monkey, 1.6 nM/dog, 4.7 nM/hamster, 3.5 nM/human, 12 nM/mouse, 4 nM/r at in cell-based assays), exhibiting no off-target activity toward 216 receptors, enzymes, and orphan GPCRs. AR231453 improves glucose tolerance in mice (3 mg/kg i.p. or 20 mg/kg, p.o.) and rats (3 mg/kg i.p.), while no in vivo efficacy is observed among GPR119-deficient mice.

in vivo

AR231453 (20 mg/kg, orally) markedly improves oral glucose tolerance in a dose-dependent fashion, with efficacy similar to maximally effective doses of the sulfonylurea glyburide[1].

Animal Model:Mice[1].
Dosage:20 mg/kg.
Administration:Orally, once.
Result:Improved glucose tolerance in mice.

References

[1] Chu ZL, et al. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology. 2007 Jun;148(6):2601-9. DOI:10.1210/en.2006-1608
[2] J Gao, et al. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist. Transplant Proc. 2011 Nov;43(9):3217-20. DOI:10.1016/j.transproceed.2011.10.021

AR 231453 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

AR 231453 Suppliers

Axon Medchem BV
Tel
--
Fax
--
Email
info@axonmedchem.com
Country
The Netherlands
ProdList
477
Advantage
30

733750-99-7, AR 231453Related Search:


  • AR 231453
  • (2-FLUORO-4-METHANESULFONYL-PHENYL)-(6-[4-(3-ISOPROPYL-[1,2,4]OXADIAZOL-5-YL)-PIPERIDIN-1-YL]-5-NITRO-PYRIMIDIN-4-YL)-AMINE
  • N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-ni
  • N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5
  • CS-2809
  • AR231453; AR-231453
  • N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amine
  • 4-Pyrimidinamine, N-[2-fluoro-4-(methylsulfonyl)phenyl]-6-[4-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-5-nitro-
  • inhibit,GPR119,AR-231453,G Protein-Coupled Receptor 119,diabetes,AR231453,AR 231453,insulin,Inhibitor,HIT-T15,glucose,GPCR
  • AR 231453, GPR119 agonist
  • AR 231453, 10 mM in DMSO
  • 733750-99-7
  • C21H24FN7O5S
  • Cannabinoids.
  • API